UK pharma major AstraZeneca has entered into a multi-target partnership with Algen Biotechnologies, the California, USA biotech announced.

US biotech AeroRx Therapeutics has secured $21 million in Series A financing to advance its lead program, AERO-007, into ...

Italian biotech NanoPhoria Bioscience has announced the successful first close of its 83.5 million euros ($97.4 million) Series A financing round.

UK-based developer of novel immunoglobulin E (IgE) antibodies to treat cancer, Epsilogen, today announced the appointment of ...

Dutch biotech uniQure recently announced that its novel gene therapy, AMT-130 (ifezuntirgene inilparvovec), demonstrated ...

Belgian biotech Bioxodes has appointed Philippe Monteyne as chairman of its board, replacing Pierre Detrixhe. The move comes ...

US lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) revealed that member companies, thanks to ...

Skye Bioscience (Nasdaq: SKYE) reported topline data from a mid-stage trial showing that its obesity drug nimacimab failed to ...

AstraZeneca (LSE: AZN) has reported positive top-line results from its second Phase III trial of baxdrostat, showing the oral therapy cut blood pressure significantly in patients with ...

Australian biotech Neurizon Therapeutics (ASX: NUZ) said the US regulator has lifted the clinical hold on its lead drug ...

Oxford, UK-based clinical-stage biotech Theolytics today announced the appointment of Dr Matilde Saggese, as chief medical ...

The atrial fibrillation (AF) market across the eight major markets (8MM) is forecast to decline at a negative compound annual ...